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Chlorpromazine (25 PM) and trifluoperazine (25 PM) inhibited by 5-fold the activity of CTP : phospho- 
choline cytidylyltransferase, the rate-limiting enzyme for phosphatidylcholine biosynthesis, in rat liver 
cytosol. Addition of saturating amounts of rat liver phospholipid to the enzyme assay rapidly reversed the 
drug-mediated inhibition. Three-fold or greater concentrations of these drugs were required to produce 
a 50% inhibition of the microsomal cytidylyltransferase. Incubation of rat hepatocytes with 20pM 
trifluoperazine or chlorpromazine did not inhibit phosphatidylcholine biosynthesis. These results provide 
additional evidence for the hypothesis that the active form of cytidylyltransferase i  on the endoplasmlc 
reticulum and the enzyme in cytosol appears to be latent. 
Phosphatidylcholine biosynthesis Rat hepatocyte Protein translocation 
1. INTRODUCTION 
The rate-limiting reaction of the CDP-choline 
pathway for phosphatidylcholine synthesis in rat 
liver is catalyzed by the regulatory enzyme, 
CTP : phosphocholine cytidylyltransferase [ 11. 
This enzyme exists in soluble and membrane- 
bound forms which are interconvertible [2]. Al- 
though ~80% of the rat liver cytidylyltransferase 
is cytosolic [3], recent studies have correlated the 
rate of phosphatidylcholine biosynthesis with the 
amount of microsomal enzyme activity [4-61. The 
microsomal cytidylyltransferase is fully active in 
the absence of exogenous phospholipid liposomes 
[7]. By contrast, the soluble enzyme purified 6-fold 
from cytosol by Sepharose 6B chromatography has 
a low basal activity but can be stimulated 50-fold 
by phospholipid liposomes [7]. Consequently, the 
hypothesis has developed that cytosol functions as 
a reservoir of inactive cytidylyltransferase which 
can be activated after translocation to the endo- 
plasmic reticulum [6,8,9]. 
Here, we have exploited the ability of various 
anaesthetics to interact with phospholipids [ 10,l l] 
to demonstrate that membrane phospholipids 
which contaminate cytosol may be responsible for 
the detectable cytidylyltransferase activity in this 
fraction. Although cytosolic cytidylyltransferase 
was extremely sensitive to inhibition by trifluo- 
perazine, chlorpromazine and tetracaine, the 
microsomal enzyme was more resistant. Further- 
more, the rate of the cytidylyltransferase-catalyzed 
reaction in monolayer cultures of rat hepatocytes 
was not substantially inhibited by the antipsychotic 
drugs, consistent with the notion that the micro- 
somal cytidylyltransferase is largely responsible for 
CDP-choline production. 
2. MATERIALS AND METHODS 
* TO whom correspondence should be addressed 
Trifluoperazine was the generous gift of Smith, 
Kline and French. All other antipsychotic drugs 
were purchased from Sigma. Cytosol and micro- 
somes were prepared from rat liver homogenized 
in 0.145 M NaCl as in [ 121. Cytidylyltransferase 
(cytosolic protein, 1.5 mg or microsomal protein, 
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1 .O mg) was preincubated in 200 ~1 with Tris-suc- 
cinate (pH 6.5) 20pmol and drug, O-240/1mol. 
The preincubation commenced with the addition 
of cytosol or microsomes at 37°C. After 10 min, 
50~1 were removed and added to 50 pl of assay 
mixture which contained [methyC3H]phosphocho- 
line (15 pCi/pmol), 150 nmol; CPT, 200 nmol and 
magnesium acetate, 750 nmol. For some incuba- 
tions, the assay mixture was resuspended in phos- 
pholipid (6 mg/ml) prepared from total rat liver 
[13]. After an additional 8 (microsomes) or 15 min 
(cytosol) at 37”C, the reaction was terminated by 
immersion of the reaction tube into boiling water 
for 2 min. Radioactivity incorporated into CDP- 
choline was determined as in [ 121. 
Hepatocytes were isolated from female Wistar 
rats (125 g) by a collagenase perfusion technique 
[14] and cultured in 60 mm diam. plastic culture 
dishes (LUX Contur) as in [ 11. Twenty hours after 
plating, hepatocytes were incubated for 2 h in 
serum-free medium (arginine-free Dulbecco’s 
modified Eagle’s medium with 28 /IM choline 
chloride, 100 nM insulin, 0.4 mM ornithine, 
100 ,ug sulphate streptomycin/ml, 100 units/ml 
penicillin G and 10 mM Hepes [4-(2-hydroxyethyl)- 
1 -piperazine-ethane sulphonic acid], pH 7.4). 
Subsequently, the medium was removed and the 
cells were pulsed for 30 min with 15 &i [methyl- 
3H]choline (0.18 Ci/mmol) dissolved in medium. 
Afterwards the cells were incubated for 90 min in 
unlabeled medium in the presence of O-100 /IM 
drug. At the end of the chase period, the cells were 
harvested and the radioactivity quantitated in the 
various choline metabolites after thin-layer chro- 
matography [ 11. 
3. RESULTS AND DISCUSSION 
The influence of various anaesthetics on the acti- 
vity of soluble cytidylyltransferase was assessed 
after a 10 min preincubation of the cytosolic en- 
zyme with the drugs (fig.1). Chlorpromazine and 
trifluoperazine (25 /rM) reduced the cytidylyltrans- 
ferase activity 5-fold, while tetracaine (50 PM) pro- 
duced 50% inhibition (fig.1, left). Moderate inhi- 
bition (28%) resulted after incubation with dibu- 
Caine or propranolol (50/1M), but lidocaine and 
procaine were without effect. Preincubation of the 
cytosolic enzyme with trifluoperazine or chlorpro- 
mazine was not required for expression of the inhi- 
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Fig.1. Effect of anaesthetic drugs on rat liver cytosolic 
cytidylyltransferase. Cytidylyltransferase activity in 
cytosol was determined in the presence of various drugs 
(O-50 ,uM) as in section 2. Left: absence of phospholipid 
liposomes; right: presence of phospholipid liposomes in 
the assay. Specific enzyme activity: chlorpromazine ( n); 
dibucaine (A); lidocalne (0); procaine (v); D,L-pro- 
pranolol (0); tetracaine (A); trifluoperazine (0). This 
experiment was repeated twice with similar results. 
bitory effects of these drugs (not shown). 
Studies with the calcium-activated, phospho- 
lipid-dependent protein kinase (protein kinase C) 
have established that inhibition of the kinase by 
anaesthetic drugs is a consequence of interaction 
of these drugs with phospholipids [15-171. Like 
protein kinase C, cytidylyltransferase can be dra- 
matically stimulated by phospholipid liposomes 
[7]. Specifically, rat liver cytosolic cytidylyltrans- 
ferase is activated by phosphatidylserine, phospha- 
tidylinositol, phosphatidylglycerol and lysophos- 
phatidylethanolamine [7]. Cytosolic cytidylyltrans- 
ferase activity was stimulated 9-fold by total rat 
liver phospholipid (compare activities without 
drugs in fig.1, left and right). Furthermore, addi- 
tion of saturating amounts of phospholipid in the 
enzyme assay rapidly reversed any inhibition of 
cytidylyltransferase activity by the antipsychotic 
drugs during the preincubation (fig.1, right). 
Hence, the observed inhibition of cytosolic cyti- 
dylyltransferase in the absence of added phospho- 
lipid by the drugs may have arisen from the inter- 
actions of the drugs with endogenous phospholipid 
[ 10,l l] which activate the enzyme. Alternatively, 
the drugs may have competitively bound to the 
sites where the phospholipids interact for activa- 
tion of the cytidylyltransferase. This latter possi- 
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bility seems less likely since drugs with different 
structures inhibited the cytosolic cytidylyltransfer- 
ase. 
Since the inhibitory action of the compounds on 
the cytosolic cytidylyltransferase activity seemed to 
be reversed by phospholipid, the microsomal cyti- 
dylyltransferase might be more resistant o inhibi- 
tion by these compounds due to a phospholipid 
rich environment. As shown in fig.2, 23-fold con- 
centrations of drug were required for 50% inhibi- 
tion of microsomal cytidylyltransferase than needed 
for an equivalent reduction of the cytosolic enzyme 
activity. Moreover, the inhibition of the micro- 
somal cytidylyltransferase by 30 pM trifluopera- 
zine was abolished by inclusion of exogenous phos- 
pholipid (not shown) or by increasing the concen- 
tration of microsomes used in the enzyme assay 
(fig.3). 
If the membrane-bound form of cytidylyltrans- 
ferase represents the active species of this enzyme 
in rat hepatocytes and this form is relatively resis- 
tant to inhibition by some of these drugs, then 
these compounds should not produce reduced rate7 
of phosphatidylcholine synthesis in intact cells. 
This hypothesis was tested in rat hepatocytes which 
had been pulsed for 30 min with [methyl-3H]cho- 
CONC. DRUG (@A) 
Fig.2. Effect of antipsychotic drugs on rat liver micro- 
somal cytidylyltransferase. Cytidylyltransferase activity 
in microsomes was determined in the presence of various 
drugs (O-6OOpM) as in section 2. Specific enzyme activity: 
chlorpromazine (m); dibucaine (A); lidocaine (0); pro- 
caine (v); D,L-propranolol (0); tetracaine (A); trifluo- 
perazine (0). This experiment was repeated 3 times with 
similar results. 
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Fig.3. Reversal of trifluoperazine inhibition of micro- 
somal cytidylyltrausferase activity by increasing [pro- 
tein] . Microsomal cytidylyltransferase was incubated for 
3-8 min at 37°C in 100~1 with Tris-succinate (pH 6.5), 
7.5 /rmol; magnesium acetate, 750 nmol; [methyl-3H]- 
phosphocholine (15 &i/pmol), 150 nmol; CTP, 
200 nmol and 0.1-l mg microsomal protein in the 
absence (0) or presence (0) of trifluoperazine, 3 nmol. 
line. At the end of the pulse period, 90% of the 
label that had not been oxidized to betaine was 
associated with the phosphocholine pool of the 
cells (not shown). The presence of the drugs in the 
chase medium did not appreciably reduce the rate 
of incorporation of label from phosphocholine 
into phosphatidylcholine after 90 min (table 1). On 
the other hand, the appearance of label into phos- 
phatidylcholine was slightly stimulated (1.3-fold, 
p<O.OS) by tetracaine or dibucaine (100 /rM). 
Since the specific radioactivity of [methyl-‘Hlphos- 
phocholine was the same in all cells at the start of 
the chase, any changes in the labeling of phospha- 
tidylcholine induced by these drugs would have 
reflected actual alterations in the rate of the cyti- 
dylyltransferase-catalyzed reaction and phosphati- 
dylcholine synthesis. These findings illustrate the 
potential difficulties in translating the effects of 
compounds on enzymes in vitro to in vivo situa- 
tions. 
The inhibitory effects of the drugs on rat liver 
cytidylyltransferase can be attributed to the ability 
of these compounds to compete with, or for, phos- 
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Table 1 
Effect of antipsychotic drugs on phosphatidylcholine 
synthesis n cultured rat hepatocytes. 
Phosphatidylcholinea Control 
(dmp x IO-‘/dish) (07.0) 
Control 
Trifluoperazine (20 CM) 
Chlorpromazine (20 ,uM) 
D,L-Propranolol 
(100 PM) 
Procaine (100 pM) 
Tetracaine (100 /rM) 
Dibucaine (100 ,uM) 
Lidocaine (100 FM) 
1.37 f 0.03 - 
1.24 f 0.10 91 
1.19 * 0.03 87 
1.50 f 0.10 109 
1.39 f 0.16 101 
1.76 f 0.13 128 
1.80 f 0.13 131 
1.27 f 0.08 93 
a Incorporation i to phosphatidylcholine during a 90 min 
chase with hepatocytes which were prelabeled with 
[methyl-‘HIcholine. The incorporation i to phosphati- 
dylcholine during the pulse period (6.3 x 10“ dpm/dish) 
has heen subtracted. 
Drugs were introduced in the chase medium of cells 
which were prelabeled with 15 ,&i of [methyl-3H]cho- 
line (0.18 Ci/nmol) for 30 min. Each value is the mean 
of three dishes, and the standard eviation is given 
pholipids which stimulate the enzyme. These 
drugs, however, have a multitude of effects, in- 
cluding antagonism of calmodulin action [ 181. 
Cytidylyltrausferase appears to be regulated by 
protein phosphorylation [12], and it is possible 
that this enzyme may be influenced by calmodu- 
lin-dependent protein phosphorylation. However, 
we would expect that an inhibition of calmodu- 
lin-dependent phosphorylation by these drugs 
would have resulted in an activation rather than an 
inhibition of cytidylyltrausferase [ 121. The findings 
with cytidylyltransferase and protein kinase C 
[15-171 demonstrate that caution must be exer- 
cised if anaesthetics are used exclusively to probe 
for calmodulin-sensitivity of enzymes which as- 
sociate with membranes. 
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